• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 106524US
Device Problems Infusion or Flow Problem (2964); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Coma (2417); Low Oxygen Saturation (2477); Respiratory Failure (2484); Ischemia Stroke (4418); Respiratory Arrest (4461)
Event Date 04/29/2022
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation conclusion: a specific cause for the reported respiratory failure and hypotension could not be conclusively determined.In addition, a direct correlation between heartmate 3 left ventricular assist system (lvas) (b)(4) and the reported events could not be conclusively established.Evaluation of the submitted log files confirmed low flow events which the account attributed to low mean arterial pressures (maps).The controller event log file captured 29 low flow fault flags, resulting in 11 low flow hazard alarms on (b)(6) 2022.The majority of the observed low flow events also appeared to be associated with elevated pi values.No other atypical events were captured.Despite these events, the pump appeared to function as intended and operated at the set speed for the duration of the file.The patient remains ongoing on heartmate 3 left ventricular assist system (lvas) (b)(4).No product is available for investigation.The relevant sections of the device history records for (b)(4) was reviewed and showed no deviations from manufacturing or quality assurance specifications.The mod cable shipped on 11-apr-2022.The current heartmate 3 (hm3) lvas instructions for use (ifu), document 100169835 rev.C, lists respiratory failure as an adverse event that may be associated with the use of the hm3 lvas.The system monitor section of the ifu describes the pump flow display and pulsatility index (4-12 through 4-16) and the hazard alarms (4-18 and 4-30).This document states that the low flow hazard alarm will be triggered when pump flow is less than 2.5lpm and explains that changes in patient conditions can result in low flow.The alarms and troubleshooting section describes the actions to take in the event of a low flow alarm (7-7 and 7-11).The heartmate 3 lvas patient handbook rev.D is also currently available.Section 5 of this handbook, entitled "alarms and troubleshooting," describes the actions to take in the event of a low flow alarm.No further information was provided.The manufacturer is closing the file on this event.
 
Event Description
It was reported that the patient had hypercapneic respiratory failure with carbon dioxide (co2) in the 80s and there was a low flow alarm followed with loss of pulsatility on (b)(6) 2022.The patient was hospitalized at the time of the event.A review of the log files confirmed the low flow alarms with high pulsatility index (pi) readings that seemed to be physiological in nature.The cause of the respiratory failure was a collapsible trachea, and the patient received many sedatives for pain control.The respiratory failure was not device related.The cause of the low flow alarms was low mean arterial pressure (maps).The patient coded.Advanced cardiac life support (acls) was started and was intubated; return of spontaneous circulation (rosc) was achieved.The patient had not been arousable and had low oxygen saturations.On (b)(6) 2022, the patient received tracheostomy and percutaneous endoscopic gastrostomy (peg) and their neurologic status was guarded.The left ventricular assist device (lvad) functioned as intended, and there were no lvad related concerns.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
lindsey sallese
6035 stoneridge drive
pleasanton, CA 94588
7818528207
MDR Report Key14488726
MDR Text Key292512776
Report Number2916596-2022-10785
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date01/13/2024
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number8385759
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/29/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Life Threatening;
Patient Age54 YR
Patient SexMale
Patient Weight103 KG
Patient EthnicityNon Hispanic
Patient RaceBlack Or African American
-
-